CAV1 and Fabry disease: Another study reported that CAV1 protein levels can be upregulated by adding acetylsalicylic acid as a supporting treatment to chaperone therapy for FD-patient-derived fibroblasts [47], revealing CAV1 as an interesting target in FD pathophysiology.